ATE47519T1 - Tabletten mit verzoegerter freisetzung sowie verfahren zu deren herstellung. - Google Patents

Tabletten mit verzoegerter freisetzung sowie verfahren zu deren herstellung.

Info

Publication number
ATE47519T1
ATE47519T1 AT85110591T AT85110591T ATE47519T1 AT E47519 T1 ATE47519 T1 AT E47519T1 AT 85110591 T AT85110591 T AT 85110591T AT 85110591 T AT85110591 T AT 85110591T AT E47519 T1 ATE47519 T1 AT E47519T1
Authority
AT
Austria
Prior art keywords
manufacture
terpolymer
pore
coating
delayed release
Prior art date
Application number
AT85110591T
Other languages
English (en)
Inventor
Stig Albin Bertil Erlandsson
Ake Rikard Lindahl
Original Assignee
Leo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Ab filed Critical Leo Ab
Application granted granted Critical
Publication of ATE47519T1 publication Critical patent/ATE47519T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Seal Device For Vehicle (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Detergent Compositions (AREA)
AT85110591T 1982-07-08 1985-08-23 Tabletten mit verzoegerter freisetzung sowie verfahren zu deren herstellung. ATE47519T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39639182A 1982-07-08 1982-07-08
EP85110591A EP0211991B1 (de) 1982-07-08 1985-08-23 Tabletten mit verzögerter Freisetzung sowie Verfahren zu deren Herstellung
CA000489999A CA1251731A (en) 1982-07-08 1985-09-04 Sustained release tablets and method for preparation thereof

Publications (1)

Publication Number Publication Date
ATE47519T1 true ATE47519T1 (de) 1989-11-15

Family

ID=37102089

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85110591T ATE47519T1 (de) 1982-07-08 1985-08-23 Tabletten mit verzoegerter freisetzung sowie verfahren zu deren herstellung.

Country Status (9)

Country Link
EP (1) EP0211991B1 (de)
JP (1) JPH0764725B2 (de)
AT (1) ATE47519T1 (de)
AU (1) AU574220B2 (de)
CA (1) CA1251731A (de)
DE (1) DE3573884D1 (de)
DK (1) DK153520C (de)
FI (1) FI86373C (de)
PT (1) PT81091B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2572618B2 (ja) * 1988-01-22 1997-01-16 日産自動車株式会社 自動車用ドアのグラスラン構造
IE60383B1 (en) * 1988-05-27 1994-07-13 Elan Corp Plc Controlled release pharmaceutical formulation
JPH0647530B2 (ja) * 1990-02-03 1994-06-22 ユニコロイド株式会社 腸疾患用薬剤カプセル及びその製法
ZA933725B (en) * 1992-05-28 1993-12-15 Elan Corp Plc Tablet formulation
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US6126970A (en) * 1995-12-01 2000-10-03 Janssen Pharmaceutica N.V. Cisapride sustained release
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
SE9903879D0 (sv) * 1999-10-28 1999-10-28 Ethical Pharmaceuticals Sweden Multipor food protection
DE19961897A1 (de) * 1999-12-20 2001-06-28 Basf Ag Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
US20030175342A1 (en) * 2002-03-14 2003-09-18 Karl Kolter Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate
WO2005019286A1 (ja) * 2003-08-20 2005-03-03 Shionogi & Co., Ltd. 新規コーティング組成物
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
JP2009507019A (ja) 2005-09-02 2009-02-19 ジェンザイム・コーポレーション リン酸塩を除去する方法およびそれに使用される重合体
CN103027896B (zh) 2005-09-15 2016-01-20 基酶有限公司 胺聚合物的小袋制剂
BRPI0717545A2 (pt) 2006-09-29 2013-10-22 Gezyme Corp Composição farmacêutica, método para tratar uma doença, polímero de amida, rede de polímero, e, método para preparar um polímero de amida
JP2010513271A (ja) 2006-12-14 2010-04-30 ゲンズイメ コーポレーション アミド−アミンポリマー組成物
EP2018860A1 (de) * 2007-07-16 2009-01-28 LEK Pharmaceuticals D.D. Duloxetinzusammensetzung
US20110008439A1 (en) * 2006-12-27 2011-01-13 Lek Pharmaceuticals D.D. Duloxetin composition
EP1938840A1 (de) * 2006-12-27 2008-07-02 LEK Pharmaceuticals D.D. Duloxetinzusammensetzung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060598A (en) * 1967-06-28 1977-11-29 Boehringer Mannheim G.M.B.H. Tablets coated with aqueous resin dispersions
SE324859B (de) * 1967-09-04 1970-06-15 Ercopharm As
US3595939A (en) * 1968-12-27 1971-07-27 Tenneco Chem Process for the production of vinyl chloride/vinyl alcohol copolymers
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
US3954959A (en) * 1973-03-28 1976-05-04 A/S Alfred Benzon Oral drug preparations
HU174057B (hu) * 1976-09-17 1979-10-28 Richter Gedeon Vegyeszet Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva
EP0096074A4 (de) * 1981-12-18 1984-05-29 Key Pharma Ausdehnbares gitter eines polyvinylalkohols und polyäthylenglykols.
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
US4432965A (en) * 1982-07-09 1984-02-21 Key Pharmaceuticals, Inc. Quinidine sustained release dosage formulation

Also Published As

Publication number Publication date
FI86373B (fi) 1992-05-15
EP0211991A1 (de) 1987-03-04
CA1251731A (en) 1989-03-28
EP0211991B1 (de) 1989-10-25
DK400785A (da) 1987-03-03
DK153520C (da) 1988-12-05
PT81091B (pt) 1988-01-22
PT81091A (en) 1985-10-01
DK400785D0 (da) 1985-09-02
JPH0764725B2 (ja) 1995-07-12
DK153520B (da) 1988-07-25
DE3573884D1 (en) 1989-11-30
AU574220B2 (en) 1988-06-30
JPS6256419A (ja) 1987-03-12
AU4693485A (en) 1987-03-05
FI86373C (fi) 1992-08-25
FI853407L (fi) 1987-03-06
FI853407A0 (fi) 1985-09-05

Similar Documents

Publication Publication Date Title
AU574220B2 (en) Sustained release drug in ter polymer coat (pvc and pvacand pvom)
ATE101340T1 (de) Neue arzneimittelformulierung sowie verfahren zu deren herstellung.
UA13038A1 (uk) Спосіб одержаhhя таблеток
DE68904326D1 (de) Physiologisch aktive substanzen enthaltende mikrosphaeren des polymilchsaeuretyps sowie verfahren zu deren herstellung.
SE8504720L (sv) Ny lekemedelsberedning
DE3485075D1 (de) Pharmazeutische zubereitung zur heilung der erkrankungen der zahnwurzelhaut und verfahren zu deren herstellung.
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
DE3481612D1 (de) Gewisse 3-amino-1-benzazepin-2-on-1-alkansaeuren, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
DE3583008D1 (de) Pharmazeutische zusammensetzungen von dihydrocodeine/ibuprofen und verfahren.
ATE145551T1 (de) Brausedosisform sowie verfahren zu deren verabreichung
HK48392A (en) Drug particles having constant release and immediate release
ATE511T1 (de) N-alkylierte aminoalkohole und ihre salze, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
DE3852145D1 (de) Indolderivate, Verfahren zu deren Herstellung und pharmazeutische Präparate, die diese enthalten.
HK60192A (en) Drug particles having constant release
SE8803822D0 (sv) Novel dosage form
ATE23266T1 (de) Pharmazeutische produkte in formen mit verzoegerter abgabe und verfahren an deren herstellung.
BE890002A (fr) Procede d'acceleration de la dissolution de substances medicamenteuses lyophilisees difficilement solubles
DE3152182A1 (de) Polymere diffusionsmatrix zur verabreichung von medikamenten
DE3681334D1 (de) Androstane-17-beta-carbonsaeureester, verfahren zu deren herstellung und pharmazeutische praeparate die diese enthalten.
FR2627986B1 (fr) Composition pharmaceutique a base de 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one ou d'un de ses sels et de dexamethasone, son procede de preparation et ses utilisations
DE68906461D1 (de) Feste arzneidosis in form eines tablettentriturats sowie verfahren zu deren herstellung.
DE2924522A1 (de) Phenanthrenderivate, verfahren zu deren herstellung sowie die phenanthrenderivate enthaltenden pharmazeutischen zusammensetzungen
ES8704080A1 (es) Metodo para producir una tableta farmaceutica revestida esencialmente con un terpolimero de poli (cloruro de vinilo) poli (acetato de vinilo) y poli (alcohol vinilico)
ATE6368T1 (de) Substituierte anthranilsaeureamide, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische praeparate und ihre herstellung.
AT349470B (de) Verfahren zur herstellung von neuen 4,4- diphenylcyclohexylpiperidinderivaten sowie deren pharmazeutisch anwendbaren saeureadditionssalzen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time